Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;28(5):1195-1205.
doi: 10.1007/s10895-018-2283-7. Epub 2018 Aug 31.

Recent Advances in Copper Intercalators as Anticancer Agents

Affiliations
Review

Recent Advances in Copper Intercalators as Anticancer Agents

C Shobha Devi et al. J Fluoresc. 2018 Sep.

Abstract

Copper is a part of various enzymes and helps them to function properly. It can be effectively used to produce promising anticancer drugs and presently, many studies are being pursued worldwide on the development of copper-based complexes as potential anticancer drugs. Herein, we briefly discuss the importance of reactive oxygen species in biological applications and copper(II) complexes as anticancer drugs. The anti-angiogenic properties of mono-nuclear copper(II) complexes have been demonstrated by in vivo chick embryo angiogenesis analysis. The plausible mechanism behind anticancer activity of these complexes is by the formation of excessive intracellular Reactive Oxygen Species (ROS). ROS is a composite term used for oxygen derivative non-radicals and free radicals of highly reactive components, that enhances the killing response of immune cells to microbial invasion. Previous reports have shown that ROS plays an important role as a messenger in cell cycling and normal cell signal transduction. Graphical Abstract The generation of singlet oxygen and healing the tumor cells with singlet oxygen in presence of UV-light.

Keywords: Angiogenesis; Cancer; Copper; DNA; ROS.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Dalton Trans. 2016 Mar 28;45(12):5339-55 - PubMed
    1. Chem Soc Rev. 2012 Apr 21;41(8):3179-92 - PubMed
    1. Met Based Drugs. 2000;7(4):185-93 - PubMed
    1. Sci Rep. 2017 Mar 24;7:45229 - PubMed
    1. Nat Rev Drug Discov. 2004 Mar;3(3):205-14 - PubMed

MeSH terms

LinkOut - more resources